Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The @IT.2020 multicenter study.

IgE allergic rhinitis component-resolved diagnostics phenotypes pollen allergy sensitization

Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
05 Feb 2024
Historique:
revised: 30 11 2023
received: 15 05 2023
accepted: 04 12 2023
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: aheadofprint

Résumé

Pollen allergy poses a significant health and economic burden in Europe. Disease patterns are relatively homogeneous within Central and Northern European countries. However, no study broadly assessed the features of seasonal allergic rhinitis (SAR) across different Southern European countries with a standardized approach. To describe sensitization profiles and clinical phenotypes of pollen allergic patients in nine Southern European cities with a uniform methodological approach. Within the @IT.2020 multicenter observational study, pediatric and adult patients suffering from SAR were recruited in nine urban study centers located in seven countries. Clinical questionnaires, skin prick tests (SPT) and specific IgE (sIgE) tests with a customized multiplex assay (Euroimmun Labordiagnostika, Lübeck, Germany) were performed. Three hundred forty-eight children (mean age 13.1 years, SD: 2.4 years) and 467 adults (mean age 35.7 years SD: 10.0 years) with a predominantly moderate to severe, persistent phenotype of SAR were recruited. Grass pollen major allergenic molecules (Phl p 1 and/or Phl p 5) ranged among the top three sensitizers in all study centers. Sensitization profiles were very heterogeneous, considering that patients in Rome were highly poly-sensitized (sIgE to 3.8 major allergenic molecules per patient), while mono-sensitization was prominent and heterogeneous in other cities, such as Marseille (sIgE to Cup a 1: n = 55/80, 68.8%) and Messina (sIgE to Par j 2: n = 47/82, 57.3%). Co-sensitization to perennial allergens, as well as allergic comorbidities also broadly varied between study centers. In Southern European countries, pollen allergy is heterogeneous in terms of sensitization profiles and clinical manifestations. Despite the complexity, a unique molecular, multiplex, and customized in-vitro IgE test detected relevant sensitization in all study centers. Nevertheless, this geographical diversity in pollen allergic patients imposes localized clinical guidelines and study protocols for clinical trials of SAR in this climatically complex region.

Sections du résumé

BACKGROUND BACKGROUND
Pollen allergy poses a significant health and economic burden in Europe. Disease patterns are relatively homogeneous within Central and Northern European countries. However, no study broadly assessed the features of seasonal allergic rhinitis (SAR) across different Southern European countries with a standardized approach.
OBJECTIVE OBJECTIVE
To describe sensitization profiles and clinical phenotypes of pollen allergic patients in nine Southern European cities with a uniform methodological approach.
METHODS METHODS
Within the @IT.2020 multicenter observational study, pediatric and adult patients suffering from SAR were recruited in nine urban study centers located in seven countries. Clinical questionnaires, skin prick tests (SPT) and specific IgE (sIgE) tests with a customized multiplex assay (Euroimmun Labordiagnostika, Lübeck, Germany) were performed.
RESULTS RESULTS
Three hundred forty-eight children (mean age 13.1 years, SD: 2.4 years) and 467 adults (mean age 35.7 years SD: 10.0 years) with a predominantly moderate to severe, persistent phenotype of SAR were recruited. Grass pollen major allergenic molecules (Phl p 1 and/or Phl p 5) ranged among the top three sensitizers in all study centers. Sensitization profiles were very heterogeneous, considering that patients in Rome were highly poly-sensitized (sIgE to 3.8 major allergenic molecules per patient), while mono-sensitization was prominent and heterogeneous in other cities, such as Marseille (sIgE to Cup a 1: n = 55/80, 68.8%) and Messina (sIgE to Par j 2: n = 47/82, 57.3%). Co-sensitization to perennial allergens, as well as allergic comorbidities also broadly varied between study centers.
CONCLUSIONS CONCLUSIONS
In Southern European countries, pollen allergy is heterogeneous in terms of sensitization profiles and clinical manifestations. Despite the complexity, a unique molecular, multiplex, and customized in-vitro IgE test detected relevant sensitization in all study centers. Nevertheless, this geographical diversity in pollen allergic patients imposes localized clinical guidelines and study protocols for clinical trials of SAR in this climatically complex region.

Identifiants

pubmed: 38311961
doi: 10.1111/all.16029
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Euroimmun

Informations de copyright

© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-743.
Bousquet PJ, Leynaert B, Neukirch F, et al. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy. 2008;63(10):1301-1309.
Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(Suppl 85):17-25.
Vandenplas O, Suarthana E, Rifflart C, Lemiere C, Le Moual N, Bousquet J. The impact of work-related rhinitis on quality of life and work productivity: a general workforce-based survey. J Allergy Clin Immunol Pract. 2020;8(5):1583-1591 e1585.
Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy. 2014;69(10):1275-1279.
Shamji MH, Sharif H, Layhadi JA, Zhu R, Kishore U, Renz H. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immunol. 2022;149(3):791-801.
Muraro A, Roberts G, Halken S, et al. EAACI guidelines on allergen immunotherapy: executive statement. Allergy. 2018;73(4):739-743.
European Environment Agency. Observed climate zones in the period 1975-1995 (left) and 1996-2016 (right). 2019 http://www.eea.europa.eu/data-and-maps/figures/observed-climate-zones-in-the/observed-climate-zones-in-the
Hoffmann TM, Acar Sahin A, Aggelidis X, et al. "Whole" vs. "fragmented" approach to EAACI pollen season definitions: a multicenter study in six Southern European Cities. Allergy. 2020;75(7):1659-1671.
Burbach GJ, Heinzerling LM, Edenharter G, et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64(10):1507-1515.
Tripodi S, Frediani T, Lucarelli S, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol. 2012;129(3):834-839.e838.
Almeida E, Caeiro E, Todo-Bom A, Duarte A, Gazarini L. Sensitization to grass allergens: Phl p1, Phl p5 and Phl p7 Phl p12 in adult and children patients in Beja (southern Portugal). Allergol Immunopathol (Madr). 2019;47(6):579-584.
Yavuz ST, Oksel Karakus C, Custovic A, Kalayci Ö. Four subtypes of childhood allergic rhinitis identified by latent class analysis. Pediatr Allergy Immunol. 2021;32(8):1691-1699.
Katotomichelakis M, Danielides G, Iliou T, et al. Allergic sensitization prevalence in a children and adolescent population of northeastern Greece region. Int J Pediatr Otorhinolaryngol. 2016;89:33-37.
Sánchez Mesa JA, Brandao R, Lopes L, Galan C. Correlation between pollen counts and symptoms in two different areas of the Iberian Peninsula: Cordoba (Spain) and Evora (Portugal). J Investig Allergol Clin Immunol. 2005;15(2):112-116.
Somoza ML, Pérez-Sánchez N, Torres-Rojas I, et al. Sensitisation to pollen allergens in children and adolescents of different ancestry born and living in the same area. J Asthma Allergy. 2022;15:1359-1367.
Zemmer F, Cenk E, Dahl Å, Galán C, Ozkaragoz F. A multidisciplinary approach of outdoor aeroallergen selection for skin prick testing in the geographical area of Greater Istanbul. Eur Ann Allergy Clin Immunol. 2022;54(1):34-42.
Caimmi D, Raschetti R, Pons P, et al. Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol. 2012;22(4):280-285.
Charpin D, Pichot C, Belmonte J, et al. Cypress pollinosis: from tree to clinic. Clin Rev Allergy Immunol. 2019;56(2):174-195.
Castillo Marchuet MJ, Luengo O, Cardona V. Cypress pollen allergy in a Mediterranean area. J Investig Allergol Clin Immunol. 2020;30(1):67.
Sin AZ, Ersoy R, Gulbahar O, Ardeniz O, Gokmen NM, Kokuludag A. Prevalence of cypress pollen sensitization and its clinical importance in Izmir, Turkey, with cypress allergy assessed by nasal provocation. J Investig Allergol Clin Immunol. 2008;18(1):46-51.
Ciprandi G, Comite P, Mussap M, et al. Profiles of birch sensitization (bet v 1, bet v 2, and bet v 4) and oral allergy syndrome across Italy. J Investig Allergol Clin Immunol. 2016;26(4):244-248.
Nuñez-Borque E, Betancor D, Fernández-Bravo S, et al. Allergen profile of London plane tree pollen: clinical and molecular pattern in central Spain. J Investig Allergol Clin Immunol. 2022;32(5):367-374.
Vrinceanu D, Berghi ON, Cergan R, et al. Urban allergy review: allergic rhinitis and asthma with plane tree sensitization (review). Exp Ther Med. 2021;21(3):275.
Pahus L, Gouitaa M, Sofalvi T, et al. Cypress pollen allergy is responsible for two distinct phenotypes of allergic rhinitis different from other pollinosis. Eur Ann Allergy Clin Immunol. 2018;50(1):28-35.
Lipp T, Acar Sahin A, Aggelidis X, et al. Heterogeneity of pollen food allergy syndrome in seven southern European countries: the @IT.2020 multicenter study. Allergy. 2021;76(10):3041-3052.
Acevedo N, Zakzuk J, Caraballo L. House dust mite allergy under changing environments. Allergy, Asthma Immunol Res. 2019;11(4):450-469.
Matricardi PM. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'. Clin Exp Immunol. 2010;160(1):98-105.
Di Fraia M, Arasi S, Castelli S, et al. A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study. Clin Exp Allergy. 2019;49(3):341-349.

Auteurs

S Dramburg (S)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

U Grittner (U)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

E Potapova (E)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

A Travaglini (A)

Department of Biology, Tor Vergata University, Rome, Italy.
Italian Aerobiology Monitoring Network - Italian Aerobiology Association, Rome, Italy.

S Tripodi (S)

Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.
Allergolology Service, Policlinico Casilino, Rome, Italy.

S Arasi (S)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pediatric Allergology Unit, Department of Pediatric Medicine, Bambino Gesù Children's Research Hospital (IRCCS), Rome, Italy.

S Pelosi (S)

TPS Production srl, Rome, Italy.

A Acar Şahin (A)

Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.

X Aggelidis (X)

Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University Hospital "Attikon", Athens, Greece.

A Barbalace (A)

Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.

A Bourgoin (A)

Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.

B Bregu (B)

Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.

M A Brighetti (MA)

Department of Biology, Tor Vergata University, Rome, Italy.

E Caeiro (E)

MED- Mediterranean Institute for Agriculture, Environment and Development, Institute for Advanced Studies and Research, University of Évora, Évora, Portugal.
Portuguese Society of Allergology and Clinical Immunology, Lisbon, Portugal.

S Caglayan Sozmen (S)

Medicana International Izmir Hospital, Izmir, Turkey.

L Caminiti (L)

Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.

D Charpin (D)

Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.

M Couto (M)

Immunoallergology, Hospital CUF Trindade, Porto, Portugal.

L Delgado (L)

Basic and Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
Allergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.

A Di Rienzo Businco (A)

Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.

C Dimier (C)

Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.

M V Dimou (MV)

Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.

J A Fonseca (JA)

CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
Allergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.
MEDCIDS-Department of Community Medicine, Information, and Health Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

O Goksel (O)

Department of Pulmonary Medicine, Division of Immunology, Allergy and Asthma. Faculty of Medicine, Ege University, Izmir, Turkey.

D Hernandez (D)

Department of Allergy, Health Research Institute Hospital La Fe, Valencia, Spain.

C J Hernandez Toro (CJ)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

T M Hoffmann (TM)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

D T Jang (DT)

Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.

F Kalpaklioglu (F)

Department of Immunology and Allergic Diseases, Kırıkkale University School of Medicine, Kırıkkale, Turkey.

B Lame (B)

Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.

R Llusar (R)

Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.

M Makris (M)

Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University Hospital "Attikon", Athens, Greece.

A Mazon (A)

Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.

E Mesonjesi (E)

Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.

A Nieto (A)

Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.

A B Öztürk (AB)

Division of Allergy and Immunology, Department of Pulmonary Medicine, Arel University, School of Medicine, Istanbul, Turkey.

L Pahus (L)

Aix Marseille Univ, APHM, INSERM CIC 1409, INSERM U1263, INRA 1260 (C2VN), Marseille, France.

G Pajno (G)

Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.

I Panasiti (I)

Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.

N G Papadopoulos (NG)

Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.

E Pellegrini (E)

Department of Reggio Calabria, ARPA - Regional Agency for Environmental Protection, Calabria, Italy.

A M Pereira (AM)

Allergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.
MEDCIDS-Department of Community Medicine, Information, and Health Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

M Pereira (M)

Basic and Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.

N M Pinar (NM)

Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.

A Priftanji (A)

Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.

F Psarros (F)

Allergy Department, Athens Naval Hospital, Athens, Greece.

C Sackesen (C)

Division of Pediatric Allergy, Koç University School of Medicine, Istanbul, Turkey.

I Sfika (I)

Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.

J Suarez (J)

Department of Biology of Organisms and Systems, Area of Botany, University of Oviedo, Oviedo, Spain.

M Thibaudon (M)

Réseau National de Surveillance Aérobiologique, Brussieu, France.

U Uguz (U)

Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.

V Verdier (V)

Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.

V Villella (V)

Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.

P Xepapadaki (P)

Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.

D Yazici (D)

Cellular and Molecular Medicine, KUTTAM, Graduate School of Health Sciences, Koç University, Istanbul, Turkey.
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

P M Matricardi (PM)

Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Classifications MeSH